Mohit Girotra1, George Triadafilopoulos2, Shai Friedland2,3. 1. Division of Gastroenterology and Hepatology, University of Miami Miller School of Medicine, Miami, FL, USA. 2. Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. 3. VA Palo Alto Health Care System, Palo Alto, CA, USA.
Abstract
BACKGROUND: Submucosal injection of a lifting agent is a critical step in endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). Literature suggests superiority of other viscous solutions over normal saline (NS), but research to determine the ideal submucosal injection is still ongoing. In this prospective cohort study, we evaluated the utility and performance characteristics of a novel submucosal injection agent (EleviewTM) for EMR and ESD. METHODS: Twelve consecutive patients referred for EMR/ESD to a tertiary referral center with experienced large polyp expert were prospectively enrolled. Ten patients with large colon polyps (mean age 66.3 years), and one patient each with esophageal and gastric lesions were included. EleviewTM was injected as submucosal lifting agent, and EMR/ESD performed. Main outcome measurements included the duration of submucosal elevation, volume and number of injections required to maintain cushion, and complications. RESULTS: Single injection of 3-5 cc of EleviewTM outlasted the duration of EMR. However, mean duration of cushion achieved during longer procedures (ESD) was 12.5 min, requiring several additional injections. R0 resection was achieved in 10/12 patients. One patient had minor bleeding which was managed intra-operatively. CONCLUSIONS: EleviewTM was successful in achieving long duration of submucosal elevation, allowing safe and efficient performance of EMR as a single injection, but needed repeated injections during longer ESD procedures. Prospective controlled trials are required to compare its performance to other available viscous submucosal solutions.
BACKGROUND: Submucosal injection of a lifting agent is a critical step in endoscopic mucosal resection (EMR), and endoscopic submucosal dissection (ESD). Literature suggests superiority of other viscous solutions over normal saline (NS), but research to determine the ideal submucosal injection is still ongoing. In this prospective cohort study, we evaluated the utility and performance characteristics of a novel submucosal injection agent (EleviewTM) for EMR and ESD. METHODS: Twelve consecutive patients referred for EMR/ESD to a tertiary referral center with experienced large polyp expert were prospectively enrolled. Ten patients with large colon polyps (mean age 66.3 years), and one patient each with esophageal and gastric lesions were included. EleviewTM was injected as submucosal lifting agent, and EMR/ESD performed. Main outcome measurements included the duration of submucosal elevation, volume and number of injections required to maintain cushion, and complications. RESULTS: Single injection of 3-5 cc of EleviewTM outlasted the duration of EMR. However, mean duration of cushion achieved during longer procedures (ESD) was 12.5 min, requiring several additional injections. R0 resection was achieved in 10/12 patients. One patient had minor bleeding which was managed intra-operatively. CONCLUSIONS: EleviewTM was successful in achieving long duration of submucosal elevation, allowing safe and efficient performance of EMR as a single injection, but needed repeated injections during longer ESD procedures. Prospective controlled trials are required to compare its performance to other available viscous submucosal solutions.
Authors: Joo Ha Hwang; Vani Konda; Barham K Abu Dayyeh; Shailendra S Chauhan; Brintha K Enestvedt; Larissa L Fujii-Lau; Sri Komanduri; John T Maple; Faris M Murad; Rahul Pannala; Nirav C Thosani; Subhas Banerjee Journal: Gastrointest Endosc Date: 2015-06-12 Impact factor: 9.427
Authors: Akira Dobashi; Andrew C Storm; Louis M Wong Kee Song; Jodie L Deters; Charles A Miller; Crystal J Tholen; Christopher J Gostout; Elizabeth Rajan Journal: Surg Endosc Date: 2019-05-08 Impact factor: 4.584
Authors: Mike T Wei; Christine Y Louie; Yu Chen; Jennifer Y Pan; Susan Y Quan; Robert Wong; Ryanne Brown; Melissa Clark; Kristin Jensen; Hubert Lau; Shai Friedland Journal: Int J Colorectal Dis Date: 2022-05-04 Impact factor: 2.571
Authors: Cristina Moles-Aranda; Raquel González-Pérez; Francisco Javier Gallego-Rojo; Olga Martínez-Augustin; Beatriz Clares-Naveros; Fermín Sánchez de Medina; José Antonio Morales-Molina Journal: J Clin Med Date: 2020-04-18 Impact factor: 4.241